StockData
Monopar Therapeutics logo

Monopar Therapeutics (MNPR) stock

MNPRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$71.97−0.03 (-0.04%)

Close on Nov 16, 2026Market cap $483.08MP/E –Yield –

Monopar Therapeutics gross margin

Gross margin is gross profit as a percentage of revenue.

No gross margin figures for Monopar Therapeutics

Monopar Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Monopar Therapeutics figures

See a number that looks wrong?